Wistar Fights COVID-19

Wistar Science. Wistar Legacy.

125 Years of Discovery and Counting

Dmitry Gabrilovich, M.D., Ph.D.

Tumor Immunology Discoveries

In 2016, Dmitry I. Gabrilovich, M.D., Ph.D., and his research team identified a marker for myeloid-derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy. The new marker has a potential clinical impact as it could be used to help direct treatment decisions and to target MDSCs for therapeutic benefit.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today